Novo Nordisk A S NVO
NYSE NVO
$38.63 +0.48 (+1.26%)
At close: Oct 9, 2026 · 4:00 PM EDT

Novo Nordisk A S (NVO) EBITDA (2012 - 2018)

Updated

Novo Nordisk A S (NVO) recorded EBITDA of $1.89 billion in Q4 2018, up 8.5% from $1.75 billion a year earlier but down 3.4% from the prior quarter.

Analysis

Novo Nordisk A S (NVO) EBITDA (2012 - 2018) Analysis & Trends

On a TTM basis, Novo Nordisk A S's EBITDA came in at $8.1 billion as of Dec 31, 2018, up 2.6% year-over-year; for FY2016, it came in at $60.13 billion.

  • Annual EBITDA has a five-year compound annual growth rate of 19.1% (FY2011 to FY2016).
  • Quarterly EBITDA has ranged from $1.6 billion in Q1 2014 to $4.97 billion in Q4 2014 over the past five years.
  • On a year-over-year basis, EBITDA rose in five of the last seven quarters, with growth averaging 3.6%.
  • Peak year-over-year performance for EBITDA in the last five years was growth of 37.6% in Q1 2015, against a decline of 13.0% in Q1 2016 at the low end.
  • Per Business Quant, the preceding three quarters came in at $1.96 billion (Q3 2018), $2.07 billion (Q2 2018) and $2.18 billion (Q1 2018).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 1.89 Bn
Sep 30, 2018 1.96 Bn
Jun 30, 2018 2.07 Bn
Mar 31, 2018 2.18 Bn
Dec 31, 2017 1.75 Bn
Sep 30, 2017 2.02 Bn
Jun 30, 2017 2.11 Bn
Mar 31, 2017 2.03 Bn
Sep 30, 2016 1.97 Bn
Jun 30, 2016 2.00 Bn
Mar 31, 2016 1.91 Bn
Sep 30, 2015 1.88 Bn
Jun 30, 2015 1.94 Bn
Mar 31, 2015 2.19 Bn
Dec 31, 2014 4.97 Bn
Sep 30, 2014 1.73 Bn
Jun 30, 2014 1.73 Bn
Mar 31, 2014 1.60 Bn
Dec 31, 2013 4.14 Bn
Sep 30, 2013 1.53 Bn
API Access

Novo Nordisk A S EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=NVO&period=max&api_key=YOUR_API_KEY